[68Ga]Ga DOTA-5G
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]Ga DOTA-5G, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) [Phase 1]